CPT code 88233 covers the laboratory process of growing tissue cultures from skin or other solid tissue biopsies to evaluate nonneoplastic disorders. This code captures a specialized pathology service that supports diagnosis when examination of cultured cells is required to clarify inflammatory, infectious, or other non-cancerous tissue processes. Nationally, accurate reporting of 88233 matters for clinical diagnosis, laboratory workflow, and appropriate payment for complex specimen processing.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for using 88233, typical sites of service, and the scope of laboratory activity it represents. The publication outlines benchmarks and utilization patterns where available, highlights relevant policy considerations affecting laboratory coverage and documentation, and situates 88233 within pathology service lines that support nonneoplastic diagnostic evaluation.

The content is intended for billing managers, laboratory directors, and health policy analysts seeking a clear, national-level summary of the code’s clinical purpose, service setting, and payer coverage landscape. Data not available in the input for associated taxonomies, specific ICD-10 pairings, and related codes is noted where applicable.